News Agency
The Times

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

  • Written by PR Newswire
  • Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations
  • Henlius to receive $31 million upfront, and up to $270 million in milestones

SHANGHAI, April 29, 2025 /PRNewswire/ -- On April 29, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) announced a licensing agreement...

Read more: Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

Selecting Steel Plate for Industrial and Fabrication Projects

Start with the job requirements A successful fabrication project starts with material that suits the work it must perform. Choosing steel plate involves more than selecting a thickness from a stock list. Designers and procurement teams need to consider the load... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion